GV20 Therapeutics has reached a milestone in its collaboration with Japan’s Mitsubishi Tanabe Pharma (TSE: 4508), pushing ...

The UK medicines regulator has reiterated that routine childhood vaccines remain safe and essential, citing decades of ...

Samsung Life Science Fund has announced an equity investment in Phrontline Biopharma, a Chinese biotech advancing a new ...

The American medicines regulator strengthened its backing for precision oncology in 2024, issuing a record 63 review ...

Denmark’s Novo Nordisk saw its shares rise 4% to 298.50 kroner today, after it announced positive headline results from a ...

The European Commission has approved Dupixent (dupilumab) for the treatment of moderate-to-severe chronic spontaneous ...

San Diego-based Aspen Neuroscience, a biotech developing autologous regenerative therapies, has announced the closing of a ...

The Russian government will create a temporary list of innovative drugs – the drugs, that will be a subject of state ...

As the debate over how to lower US drug prices continues, the Inflation Reduction Act (IRA) drug price-setting provisions ...

The US District Court for the District of Columbia has rejected Israel-headquartered Teva Pharmaceuticals Industries’ ...

US–Dutch–Chinese biotech Harbour BioMed (HKEX: 02142) has extended its partnership with British pharma major AstraZeneca (LSE ...

The Russian drugmaker Akselpharm has successfully defended its patent for osimertinib the active ingredient of UK pharma ...